HCPCS Level II
HCPCS Level II 2000 code changes
Every HCPCS Level II code whose CMS add date or termination date falls in 2000, grouped by effective date. Each code's own page carries its full record.
196
Added
0
Deleted
For HCPCS Level II, MedCoder records each code's CMS add date and termination date from the alpha-numeric file. A deletion is listed on the first day the code is no longer valid (the day after its CMS termination date). Description revisions between quarterly files are not recorded as changes.
Added effective January 1, 2000 (179)
- A4280 — Adhesive skin support attachment for use with external breast prosthesis, each
- A4369 — Ostomy skin barrier, liquid (spray, brush, etc.), per oz
- A4371 — Ostomy skin barrier, powder, per oz
- A4372 — Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each
- A4373 — Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each
- A4375 — Ostomy pouch, drainable, with faceplate attached, plastic, each
- A4376 — Ostomy pouch, drainable, with faceplate attached, rubber, each
- A4377 — Ostomy pouch, drainable, for use on faceplate, plastic, each
- A4378 — Ostomy pouch, drainable, for use on faceplate, rubber, each
- A4379 — Ostomy pouch, urinary, with faceplate attached, plastic, each
- A4380 — Ostomy pouch, urinary, with faceplate attached, rubber, each
- A4381 — Ostomy pouch, urinary, for use on faceplate, plastic, each
- A4382 — Ostomy pouch, urinary, for use on faceplate, heavy plastic, each
- A4383 — Ostomy pouch, urinary, for use on faceplate, rubber, each
- A4384 — Ostomy faceplate equivalent, silicone ring, each
- A4385 — Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each
- A4387 — Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each
- A4388 — Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each
- A4389 — Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each
- A4390 — Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each
- A4391 — Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each
- A4392 — Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each
- A4393 — Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each
- A4394 — Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce
- A4395 — Ostomy deodorant for use in ostomy pouch, solid, per tablet
- A5508 — For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe
- A7000 — Canister, disposable, used with suction pump, each
- A7001 — Canister, non-disposable, used with suction pump, each
- A7002 — Tubing, used with suction pump, each
- A7003 — Administration set, with small volume nonfiltered pneumatic nebulizer, disposable
- A7004 — Small volume nonfiltered pneumatic nebulizer, disposable
- A7005 — Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable
- A7006 — Administration set, with small volume filtered pneumatic nebulizer
- A7007 — Large volume nebulizer, disposable, unfilled, used with aerosol compressor
- A7008 — Large volume nebulizer, disposable, prefilled, used with aerosol compressor
- A7009 — Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer
- A7010 — Corrugated tubing, disposable, used with large volume nebulizer, 100 feet
- A7011 — Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet
- A7012 — Water collection device, used with large volume nebulizer
- A7013 — Filter, disposable, used with aerosol compressor or ultrasonic generator
- A7014 — Filter, nondisposable, used with aerosol compressor or ultrasonic generator
- A7015 — Aerosol mask, used with dme nebulizer
- A7016 — Dome and mouthpiece, used with small volume ultrasonic nebulizer
- A7017 — Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9900 — Miscellaneous dme supply, accessory, and/or service component of another hcpcs code
- A9901 — Dme delivery, set up, and/or dispensing service component of another hcpcs code
- E0144 — Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat
- E0602 — Breast pump, manual, any type
- E0616 — Implantable cardiac event recorder with memory, activator and programmer
- E0779 — Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater
- E0780 — Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours
- E1390 — Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate
- G0102 — Prostate cancer screening; digital rectal examination
- G0103 — Prostate cancer screening; prostate specific antigen test (psa)
- G0166 — External counterpulsation, per treatment session
- G0168 — Wound closure utilizing tissue adhesive(s) only
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0456 — Injection, azithromycin, 500 mg
- J1327 — Injection, eptifibatide, 5 mg
- J1438 — Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J1450 — Injection fluconazole, 200 mg
- J1745 — Injection, infliximab, excludes biosimilar, 10 mg
- J2543 — Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2780 — Injection, ranitidine hydrochloride, 25 mg
- J7198 — Anti-inhibitor, per i.u.
- J7199 — Hemophilia clotting factor, not otherwise classified
- J7502 — Cyclosporine, oral, 100 mg
- J7515 — Cyclosporine, oral, 25 mg
- J7516 — Injection, cyclosporine, 250 mg
- J7517 — Mycophenolate mofetil, oral, 250 mg
- J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7628 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629 — Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631 — Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7635 — Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636 — Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637 — Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638 — Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7639 — Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7642 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643 — Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7648 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7649 — Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7658 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7659 — Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7668 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
- J7669 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7680 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683 — Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684 — Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J8510 — Busulfan; oral, 2 mg
- J8520 — Capecitabine, oral, 150 mg
- J8521 — Capecitabine, oral, 500 mg
- J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg
- J9357 — Injection, valrubicin, intravesical, 200 mg
- L3807 — Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
- L9900 — Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs "l" code
- P9023 — Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit
- S0012 — Butorphanol tartrate, nasal spray, 25 mg
- S0014 — Tacrine hydrochloride, 10 mg
- S0017 — Injection, aminocaproic acid, 5 grams
- S0020 — Injection, bupivicaine hydrochloride, 30 ml
- S0021 — Injection, cefoperazone sodium, 1 gram
- S0023 — Injection, cimetidine hydrochloride, 300 mg
- S0028 — Injection, famotidine, 20 mg
- S0030 — Injection, metronidazole, 500 mg
- S0032 — Injection, nafcillin sodium, 2 grams
- S0034 — Injection, ofloxacin, 400 mg
- S0039 — Injection, sulfamethoxazole and trimethoprim, 10 ml
- S0040 — Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
- S0073 — Injection, aztreonam, 500 mg
- S0074 — Injection, cefotetan disodium, 500 mg
- S0077 — Injection, clindamycin phosphate, 300 mg
- S0078 — Injection, fosphenytoin sodium, 750 mg
- S0080 — Injection, pentamidine isethionate, 300 mg
- S0081 — Injection, piperacillin sodium, 500 mg
- S0090 — Sildenafil citrate, 25 mg
- S0601 — Screening proctoscopy
- S0610 — Annual gynecological examination, new patient
- S0612 — Annual gynecological examination, established patient
- S0620 — Routine ophthalmological examination including refraction; new patient
- S0621 — Routine ophthalmological examination including refraction; established patient
- S0800 — Laser in situ keratomileusis (lasik)
- S0810 — Photorefractive keratectomy (prk)
- S2053 — Transplantation of small intestine and liver allografts
- S2054 — Transplantation of multivisceral organs
- S2055 — Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor
- S2205 — Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft
- S2206 — Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts
- S2207 — Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft
- S2208 — Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft
- S2209 — Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft
- S2300 — Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy
- S2350 — Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace
- S2351 — Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)
- S3645 — Hiv-1 antibody testing of oral mucosal transudate
- S3650 — Saliva test, hormone level; during menopause
- S3652 — Saliva test, hormone level; to assess preterm labor risk
- S8035 — Magnetic source imaging
- S8040 — Topographic brain mapping
- S8092 — Electron beam computed tomography (also known as ultrafast ct, cine ct)
- S8096 — Portable peak flow meter
- S8110 — Peak expiratory flow rate (physician services)
- S8950 — Complex lymphedema therapy, each 15 minutes
- S9001 — Home uterine monitor with or without associated nursing services
- S9024 — Paranasal sinus ultrasound
- S9055 — Procuren or other growth factor preparation to promote wound healing
- S9056 — Coma stimulation per diem
- S9090 — Vertebral axial decompression, per session
- S9122 — Home health aide or certified nurse assistant, providing care in the home; per hour
- S9123 — Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)
- S9124 — Nursing care, in the home; by licensed practical nurse, per hour
- S9125 — Respite care, in the home, per diem
- S9126 — Hospice care, in the home, per diem
- S9127 — Social work visit, in the home, per diem
- S9128 — Speech therapy, in the home, per diem
- S9129 — Occupational therapy, in the home, per diem
- S9140 — Diabetic management program, follow-up visit to non-md provider
- S9141 — Diabetic management program, follow-up visit to md provider
- S9455 — Diabetic management program, group session
- S9460 — Diabetic management program, nurse visit
- S9465 — Diabetic management program, dietitian visit
- S9470 — Nutritional counseling, dietitian visit
- S9472 — Cardiac rehabilitation program, non-physician provider, per diem
- S9473 — Pulmonary rehabilitation program, non-physician provider, per diem
- S9474 — Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem
- S9475 — Ambulatory setting substance abuse treatment or detoxification services, per diem
- S9480 — Intensive outpatient psychiatric services, per diem
- S9485 — Crisis intervention mental health services, per diem
- S9990 — Services provided as part of a phase ii clinical trial
- S9991 — Services provided as part of a phase iii clinical trial
- S9992 — Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion
- S9994 — Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion
- S9996 — Meals for clinical trial participant and one caregiver/companion
- S9999 — Sales tax
Added effective April 1, 2000 (1)
- G0129 — Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization or intensive outpatient treatment program, per session (45 minutes or more)
Added effective July 1, 2000 (5)
- G0175 — Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present
- Q2004 — Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
- Q2009 — Injection, fosphenytoin, 50 mg phenytoin equivalent
- Q2017 — Injection, teniposide, 50 mg
- Q3001 — Radioelements for brachytherapy, any type, each
Added effective August 1, 2000 (2)
Added effective October 1, 2000 (9)
- G0180 — Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care
- G9001 — Coordinated care fee, initial rate
- G9002 — Coordinated care fee, maintenance rate
- G9003 — Coordinated care fee, risk adjusted high, initial
- G9004 — Coordinated care fee, risk adjusted low, initial
- G9005 — Coordinated care fee, risk adjusted maintenance
- G9006 — Coordinated care fee, home monitoring
- G9007 — Coordinated care fee, scheduled team conference
- G9008 — Coordinated care fee, physician coordinated care oversight services
Source: CMS HCPCS Level II alpha-numeric file (add and termination dates).
Source data
- Source organization
- CMS
- Source release
- HCPCS Level II October 2026 alpha-numeric file
- Source file
- october-2026-alpha-numeric-hcpcs-file.zip
- File checksum (SHA-256)
- c25240c63108756d4ba6c0ea785c517117d83bfed9526c51da8acf123de1feb6
- Data read date
- Data not available in the current MedCoder release record.
- Effective date
- CMS effective dates within 2000
- Release type
- Quarterly (January, April, July, October), with occasional mid-quarter additions
- Methodology
- Each code's add date and termination date are read from the alpha-numeric file. A deletion is dated the first day the code is no longer valid, the day after its termination date. Description revisions are not recorded as changes.
These changes are based on recorded release data. MedCoder does not generate coding changes with AI.